Recombinant multi-species Mast Cell Chymase/CMA1/CYM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Mast Cell Chymase/CMA1/CYM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a chymotryptic serine proteinase that belongs to the peptidase family S1. It is expressed in mast cells and is thought to function in the degradation of the extracellular matrix, the regulation of submucosal gland secretion, and the generation of vasoactive peptides. In the heart and blood vessels, this protein, rather than angiotensin converting enzyme, is largely responsible for converting angiotensin I to the vasoactive peptide angiotensin II. Alternative splicing results in multiple variants. [provided by RefSeq, Apr 2015]
The Alternative Names of target: Alpha-chymase,CMA1,CYH,CYM,Chymase,Cma1,MCT1,MMCP-5,Mast Cell Chymase,Mast cell protease I,Mcp-5,Mcp5,Mcpt5,chymase

Target products collectionGo to Mast Cell Chymase/CMA1/CYM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T05114-Ag-1/ GM-Tg-hg-T05114-Ag-2 Human Mast Cell Chymase/CMA1/CYM protein Human
GM-Tg-rg-T05114-Ag-1/ GM-Tg-rg-T05114-Ag-2 Rat Mast Cell Chymase/CMA1/CYM protein Rat
GM-Tg-mg-T05114-Ag-1/ GM-Tg-mg-T05114-Ag-2 Mouse Mast Cell Chymase/CMA1/CYM protein Mouse
GM-Tg-cynog-T05114-Ag-1/ GM-Tg-cynog-T05114-Ag-2 Cynomolgus/Rhesus macaque Mast Cell Chymase/CMA1/CYM protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T05114-Ag-1/ GM-Tg-felg-T05114-Ag-2 Feline Mast Cell Chymase/CMA1/CYM protein Feline
GM-Tg-cang-T05114-Ag-1/ GM-Tg-cang-T05114-Ag-2 Canine Mast Cell Chymase/CMA1/CYM protein Canine
GM-Tg-bovg-T05114-Ag-1/ GM-Tg-bovg-T05114-Ag-2 Bovine Mast Cell Chymase/CMA1/CYM protein Bovine
GM-Tg-equg-T05114-Ag-1/ GM-Tg-equg-T05114-Ag-2 Equine Mast Cell Chymase/CMA1/CYM protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T05114-Ag-1/ GM-Tg-hg-T05114-Ag-2; GM-Tg-rg-T05114-Ag-1/ GM-Tg-rg-T05114-Ag-2;
GM-Tg-mg-T05114-Ag-1/ GM-Tg-mg-T05114-Ag-2; GM-Tg-cynog-T05114-Ag-1/ GM-Tg-cynog-T05114-Ag-2;
GM-Tg-felg-T05114-Ag-1/ GM-Tg-felg-T05114-Ag-2; GM-Tg-cang-T05114-Ag-1/ GM-Tg-cang-T05114-Ag-2;
GM-Tg-bovg-T05114-Ag-1/ GM-Tg-bovg-T05114-Ag-2; GM-Tg-equg-T05114-Ag-1/ GM-Tg-equg-T05114-Ag-2
Products Name Mast Cell Chymase/CMA1/CYM protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Mast Cell Chymase/CMA1/CYM
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Mast Cell Chymase/CMA1/CYM protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.